Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of β-hydroxylase for treatment of cancer

Inhibitors of β-hydroxylase for treatment of cancer

US Patent 10351555 · Granted Jul 16, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Isotopically-stabilized tetronimide compounds2024
Methods of using monoclonal antibodies targeting epitopes of ASPH2022
Isotopically-stabilized tetronimide compounds2021
Monoclonal antibodies targeting epitopes of ASPH2021
Inhibitors of beta-hydroxylase for treatment of cancer2020
Inhibitors of beta-hydroxylase for treatment of cancer2020
Inhibitors of β-hydroxylase for treatment of cancer2020
Inhibitors of β-hydroxylase for treatment of cancer2020
Inhibitors of beta-hydroxylase for treatment of cancer2018
Inhibitors of beta-hydroxylase for treatment of cancer2018
Inhibitors of beta-hydroxylase for treatment of cancer2017
Inhibitors of beta-hydroxylase for treatment of cancer2017